Deciphera Pharmaceuticals Inc (OQ:DCPH)

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for DCPH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 13/19 Dec 12/19 Flynn Daniel Lee Indirect Ownership Common Stock S - Open market or private sale -31,029 $60.00
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,034  
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Common Stock S - Open market or private sale -15,034 $60.00
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,034 $3.95
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 11,647  
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Common Stock S - Open market or private sale -11,647 $55.00
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,647 $3.95
Dec 11/19 Dec 10/19 Flynn Daniel Lee Direct Ownership Common Stock S - Open market or private sale -93,930 $55.00
Dec 11/19 Dec 10/19 Flynn Daniel Lee Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 93,930 $1.89
Dec 11/19 Dec 10/19 Flynn Daniel Lee Direct Ownership Common Stock S - Open market or private sale -28,822 $55.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DCPH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 13/19 Dec 12/19 Flynn Daniel Lee Indirect Ownership Common Stock S - Open market or private sale -31,029 $60.00
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,034  
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Common Stock S - Open market or private sale -15,034 $60.00
Dec 13/19 Dec 12/19 Morl Christopher John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,034 $3.95
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 11,647  
Dec 11/19 Dec 9/19 Morl Christopher John Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 3,387  
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Common Stock S - Open market or private sale -11,647 $55.00
Dec 11/19 Dec 10/19 Morl Christopher John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,647 $3.95
Dec 11/19 Dec 9/19 Morl Christopher John Direct Ownership Common Stock S - Open market or private sale -3,387 $55.00
Dec 11/19 Dec 9/19 Morl Christopher John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,387 $3.95
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $DCPH